Catalent stock rises with $1 billion deal to buy supplement maker Bettera

Catalent (CTLT) – Received Catalent Inc Report shares rose Monday after the contract drug manufacturer said it is buying Bettera, a maker of gummy nutritional supplements, for $1 billion in cash.

.